日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/04/04 | 7,280 | 7,310 | 7,210 | 7,270 | -10 | -0.1% | 160,500 |
| 2018/04/03 | 6,970 | 7,320 | 6,950 | 7,280 | +220 | +3.1% | 339,800 |
| 2018/04/02 | 7,230 | 7,290 | 7,060 | 7,060 | -60 | -0.8% | 166,900 |
| 2018/03/30 | 7,200 | 7,210 | 7,070 | 7,120 | -20 | -0.3% | 179,400 |
| 2018/03/29 | 7,070 | 7,170 | 6,930 | 7,140 | +40 | +0.6% | 263,700 |
| 2018/03/28 | 7,120 | 7,180 | 7,050 | 7,100 | -110 | -1.5% | 211,600 |
| 2018/03/27 | 7,250 | 7,300 | 7,150 | 7,210 | +20 | +0.3% | 298,600 |
| 2018/03/26 | 6,870 | 7,190 | 6,870 | 7,190 | +370 | +5.4% | 453,400 |
| 2018/03/23 | 6,800 | 6,920 | 6,790 | 6,820 | -120 | -1.7% | 378,300 |
| 2018/03/22 | 6,870 | 6,960 | 6,800 | 6,940 | -30 | -0.4% | 412,400 |
| 2018/03/20 | 7,080 | 7,080 | 6,900 | 6,970 | +80 | +1.2% | 370,500 |
| 2018/03/19 | 6,950 | 6,970 | 6,780 | 6,890 | -170 | -2.4% | 313,700 |
| 2018/03/16 | 6,950 | 7,090 | 6,900 | 7,060 | +210 | +3.1% | 603,000 |
| 2018/03/15 | 6,870 | 6,960 | 6,830 | 6,850 | +50 | +0.7% | 359,700 |
| 2018/03/14 | 6,750 | 6,850 | 6,700 | 6,800 | +20 | +0.3% | 363,500 |
| 2018/03/13 | 6,690 | 6,790 | 6,670 | 6,780 | +50 | +0.7% | 256,800 |
| 2018/03/12 | 6,700 | 6,810 | 6,690 | 6,730 | +130 | +2% | 351,600 |
| 2018/03/09 | 6,710 | 6,710 | 6,590 | 6,600 | +90 | +1.4% | 524,900 |
| 2018/03/08 | 6,470 | 6,530 | 6,400 | 6,510 | +140 | +2.2% | 481,600 |
| 2018/03/07 | 6,140 | 6,400 | 6,130 | 6,370 | +170 | +2.7% | 535,700 |
| 2018/03/06 | 6,200 | 6,240 | 6,150 | 6,200 | +60 | +1% | 464,600 |
| 2018/03/05 | 5,940 | 6,170 | 5,930 | 6,140 | +160 | +2.7% | 577,800 |
| 2018/03/02 | 5,800 | 6,040 | 5,780 | 5,980 | +80 | +1.4% | 438,300 |
| 2018/03/01 | 5,960 | 5,960 | 5,860 | 5,900 | -120 | -2% | 308,300 |
| 2018/02/28 | 5,900 | 6,170 | 5,880 | 6,020 | +100 | +1.7% | 506,600 |
| 2018/02/27 | 6,030 | 6,030 | 5,820 | 5,920 | -50 | -0.8% | 485,100 |
| 2018/02/26 | 5,940 | 5,990 | 5,890 | 5,970 | +100 | +1.7% | 526,900 |
| 2018/02/23 | 5,870 | 5,920 | 5,800 | 5,870 | -40 | -0.7% | 651,500 |
| 2018/02/22 | 6,050 | 6,100 | 5,900 | 5,910 | -270 | -4.4% | 588,300 |
| 2018/02/21 | 6,200 | 6,280 | 5,980 | 6,180 | -110 | -1.7% | 620,100 |
| 2018/02/20 | 6,340 | 6,410 | 6,280 | 6,290 | -80 | -1.3% | 241,500 |
| 2018/02/19 | 6,280 | 6,400 | 6,260 | 6,370 | +120 | +1.9% | 212,100 |
| 2018/02/16 | 6,190 | 6,310 | 6,180 | 6,250 | +90 | +1.5% | 199,700 |
| 2018/02/15 | 6,080 | 6,210 | 6,080 | 6,160 | +100 | +1.7% | 304,000 |
| 2018/02/14 | 6,260 | 6,260 | 6,050 | 6,060 | -200 | -3.2% | 425,700 |
| 2018/02/13 | 6,420 | 6,430 | 6,230 | 6,260 | -130 | -2% | 414,400 |
| 2018/02/09 | 6,470 | 6,470 | 6,270 | 6,390 | -300 | -4.5% | 328,300 |
| 2018/02/08 | 6,750 | 6,780 | 6,650 | 6,690 | ±0 | ±0% | 292,000 |
| 2018/02/07 | 6,940 | 7,030 | 6,660 | 6,690 | -230 | -3.3% | 542,100 |
| 2018/02/06 | 6,960 | 7,000 | 6,760 | 6,920 | -440 | -6% | 334,500 |
| 2018/02/05 | 7,460 | 7,530 | 7,350 | 7,360 | -250 | -3.3% | 167,400 |
| 2018/02/02 | 7,600 | 7,640 | 7,530 | 7,610 | -20 | -0.3% | 222,300 |
| 2018/02/01 | 7,550 | 7,630 | 7,520 | 7,630 | +120 | +1.6% | 149,100 |
| 2018/01/31 | 7,580 | 7,670 | 7,510 | 7,510 | -120 | -1.6% | 275,300 |
| 2018/01/30 | 7,710 | 7,770 | 7,600 | 7,630 | -110 | -1.4% | 228,400 |
| 2018/01/29 | 7,800 | 7,870 | 7,720 | 7,740 | -60 | -0.8% | 181,900 |
| 2018/01/26 | 7,880 | 7,890 | 7,770 | 7,800 | +10 | +0.1% | 217,200 |
| 2018/01/25 | 7,900 | 7,950 | 7,760 | 7,790 | -70 | -0.9% | 219,500 |
| 2018/01/24 | 7,990 | 8,020 | 7,800 | 7,860 | -190 | -2.4% | 432,500 |
| 2018/01/23 | 8,100 | 8,120 | 8,030 | 8,050 | ±0 | ±0% | 189,800 |
1751～
1800
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
